Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Change in Receivables (2016 - 2024)

Historic Change in Receivables for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to -$180000.0.

  • vTv Therapeutics' Change in Receivables fell 27647.06% to -$180000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was -$40000.0, marking a year-over-year increase of 4366.2%. This contributed to the annual value of -$40000.0 for FY2024, which is 4366.2% up from last year.
  • vTv Therapeutics' Change in Receivables amounted to -$180000.0 in Q4 2024, which was down 27647.06% from -$64000.0 recorded in Q3 2024.
  • In the past 5 years, vTv Therapeutics' Change in Receivables ranged from a high of $928000.0 in Q3 2021 and a low of -$871000.0 during Q4 2021
  • Over the past 5 years, vTv Therapeutics' median Change in Receivables value was -$2000.0 (recorded in 2021), while the average stood at $4133.3.
  • Examining YoY changes over the last 5 years, vTv Therapeutics' Change in Receivables showed a top increase of 652857.14% in 2021 and a maximum decrease of 70486.11% in 2021.
  • Quarter analysis of 5 years shows vTv Therapeutics' Change in Receivables stood at $144000.0 in 2020, then tumbled by 704.86% to -$871000.0 in 2021, then soared by 113.32% to $116000.0 in 2022, then fell by 12.07% to $102000.0 in 2023, then crashed by 276.47% to -$180000.0 in 2024.
  • Its last three reported values are -$180000.0 in Q4 2024, -$64000.0 for Q3 2024, and -$675000.0 during Q2 2024.